Johnson & Johnson Development Corporation (JJDC) is the strategic venture capital division of Johnson & Johnson. They focus their investments across pharmaceutical, medical devices and consumer healthcare sectors at all stages. Their investments take a long-term approach in which they use the resources of Johnson & Johnson to support their companies, which includes discovery, clinical development, regulatory affairs, manufacturing and commercialization.
Johnson & Johnson Development Corporation has made investments in CVRx, Grail, Fusion Pharmaceuticals, Brainsgate, ReVision Optics, CoAxia, Cala Health and PhaseBio Pharmaceuticals.
They exited their investments in NovoCure, Nevro, Inspire Medical Systems, Biocartis, Mazor Robotics, Aduro BioTech, PowerVision, Neotract, Genocea Biosciences, Merus, PhaseBio Pharmaceuticals and Protagonist Therapeutics.
